Jeff Yass’s Eledon Pharmaceuticals ELDN Stock Holding History

Jeff Yass’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$236K	Buy	+59,900	New	+$218K	﹤0.01%	11595
2025 Q3	–	Sell	-17,300	Closed	-$46.9K	–	12712
2025 Q2	$46.9K	Buy	+17,300	New	+$51.9K	﹤0.01%	12131
2022 Q4	–	Sell	-14,500	Closed	-$40K	–	12711
2022 Q3	$40K	Buy	+14,500	New	+$46.2K	﹤0.01%	12329
2022 Q1	–	Sell	-18,100	Closed	-$80K	–	13195
2021 Q4	$80K	Buy	+18,100	New	+$91.6K	﹤0.01%	12281
2016 Q3	–	Sell	-62	Closed	-$55K	–	8520
2016 Q2	$55K	Buy	+62	New	+$68.4K	﹤0.01%	8218

Other funds holding ELDN

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Catalio Capital Management New York $532M AUM 166.55% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Jeff Yass's ELDN Position: Q2 2026 in Review

Jeff Yass increased its Eledon Pharmaceuticals (ELDN) stake by 129% in Q2 2026, buying an estimated $517K and bringing the position to 252,232 shares worth $994K. The position accounts for ﹤0.01% of the portfolio, ranked #8218.

Jeff Yass first reported a position in ELDN in Q4 2014 and has held it in 19 quarters since. The position peaked at $5.38M in Q1 2025. 159 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

Jeff Yass held 252,232 shares of Eledon Pharmaceuticals worth $994K as of Q2 2026.
Jeff Yass bought 142,283 Eledon Pharmaceuticals shares in Q2 2026, an estimated $517K.
Eledon Pharmaceuticals made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8218 holding.
Jeff Yass first reported a position in Eledon Pharmaceuticals in Q4 2014 and has held it in 19 quarters since.
Jeff Yass's Eledon Pharmaceuticals position peaked at $5.38M in Q1 2025.
159 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.